Chemed (CHE) Non-Current Deffered Revenue (2009 - 2026)

Chemed's Non-Current Deffered Revenue history runs 18 years deep, the most recent figure standing at $142.7 million for Q1 2026.

• In Q1 2026, Non-Current Deffered Revenue rose 12.07% year-over-year to $142.7 million; the TTM figure through Mar 2026 stood at $142.7 million (up 12.07% YoY), while the FY2025 annual figure was $136.1 million, up 8.02% from the prior year.
• Non-Current Deffered Revenue was $142.7 million for Q1 2026 at Chemed, up from $136.1 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $142.7 million in Q1 2026 to a low of $89.9 million in Q3 2022.
• Historically, Non-Current Deffered Revenue has averaged $113.7 million across 5 years, with a median of $117.6 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Non-Current Deffered Revenue dropped 10.49% in 2022, then climbed 21.11% in 2024.
• A 5-year view of Non-Current Deffered Revenue shows it stood at $92.3 million in 2022, then increased by 12.71% to $104.1 million in 2023, then increased by 21.11% to $126.0 million in 2024, then advanced by 8.02% to $136.1 million in 2025, then advanced by 4.79% to $142.7 million in 2026.
• The last three Non-Current Deffered Revenue figures came in at $142.7 million (Q1 2026), $136.1 million (Q4 2025), and $132.4 million (Q3 2025), per Business Quant data.